(Q51344453)

3 April 2018

meta-analysis

0 references

title

l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. (English)

1 reference

3 April 2018

main subject

liver cirrhosis

0 references

hepatic encephalopathy

1 reference

1 reference

Ming Bai

1

1 reference

3 April 2018

Zhiping Yang

2

1 reference

3 April 2018

Xingshun Qi

3

1 reference

3 April 2018

Daiming Fan

4

1 reference

3 April 2018

Guohong Han

5

1 reference

3 April 2018

publication date

1 May 2013

1 reference

3 April 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

3 April 2018

volume

28

1 reference

3 April 2018

issue

5

1 reference

3 April 2018

page(s)

783-792

1 reference

3 April 2018

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

cites work

1 reference

New assessment of hepatic encephalopathy

21 January 2018

1 reference

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients

21 January 2018

1 reference

Review article: the burden of hepatic encephalopathy

21 January 2018

1 reference

Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test

21 January 2018

1 reference

Pathogenetic mechanisms of hepatic encephalopathy

21 January 2018

1 reference

Correlation between ammonia levels and the severity of hepatic encephalopathy.

21 January 2018

1 reference

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

21 January 2018

1 reference

21 January 2018

Hepatic Encephalopathy.

1 reference

The treatment of hepatic encephalopathy

21 January 2018

1 reference

Current concepts in the assessment and treatment of hepatic encephalopathy

21 January 2018

1 reference

Nonabsorbable disaccharides for hepatic encephalopathy

21 January 2018

1 reference

Dopaminergic agonists for hepatic encephalopathy

21 January 2018

1 reference

Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis

21 January 2018

1 reference

Probiotics for patients with hepatic encephalopathy

21 January 2018

1 reference

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

21 January 2018

1 reference

A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis

21 January 2018

1 reference

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy

21 January 2018

1 reference

A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.

21 January 2018

1 reference

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

21 January 2018

1 reference

L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure

21 January 2018

1 reference

L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.

21 January 2018

1 reference

L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis

21 January 2018

1 reference

What contributions do languages other than English make on the results of meta-analyses?

21 January 2018

1 reference

Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy.

21 January 2018

1 reference

Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12142

1 reference

3 April 2018

1 reference

3 April 2018